1,2-dimethylhydrazine increases expression ISO RGD:1557220 6480464 1, 2-Dimethylhydrazine results in increased expression of PML mRNA CTD PMID:22206623 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1557220 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557220 6480464 Tetrachlorodibenzodioxin results in increased expression of PML mRNA CTD PMID:19933214 , PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557220 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:25975270 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557220 6480464 Tetrachlorodibenzodioxin affects the expression of PML mRNA CTD PMID:21570461 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1562602 6480464 tetrabromobisphenol A results in increased expression of PML mRNA CTD PMID:27914987 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 4'-epidoxorubicin affects mutagenesis EXP 6480464 Epirubicin affects the mutagenesis of PML gene CTD PMID:19884644 4,4'-diaminodiphenylmethane increases expression ISO RGD:1557220 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PML mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1557220 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PML exon CTD PMID:33297965 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of PML mRNA CTD PMID:19194470 6-propyl-2-thiouracil affects expression ISO RGD:1562602 6480464 Propylthiouracil affects the expression of PML mRNA CTD PMID:24780913 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:1557220 6480464 PML protein promotes the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of IL1B protein] more ... CTD PMID:23430110 acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PML mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PML mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1557220 6480464 Aflatoxin B1 results in increased expression of PML mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PML mRNA CTD PMID:21641981 all-trans-retinoic acid affects localization EXP 6480464 Tretinoin affects the localization of PML protein CTD PMID:9834237 all-trans-retinoic acid increases response to substance EXP 6480464 PML protein mutant form results in increased susceptibility to Tretinoin CTD PMID:32929351 all-trans-retinoic acid increases degradation EXP 6480464 Tretinoin results in increased degradation of PML protein mutant form CTD PMID:15748426 more ... all-trans-retinoic acid increases phosphorylation EXP 6480464 Tretinoin results in increased phosphorylation of PML protein mutant form CTD PMID:19029980 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of PML mRNA CTD PMID:16249480 all-trans-retinoic acid increases cleavage EXP 6480464 Tretinoin results in increased cleavage of PML protein mutant form CTD PMID:12130515 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PML mRNA, Tretinoin results in increased expression of PML protein CTD PMID:12015078 , PMID:33167477 all-trans-retinoic acid multiple interactions EXP 6480464 [PML protein mutant form results in increased susceptibility to Tretinoin] which results in increased abundance of and results in increased secretion of Triglycerides more ... CTD PMID:12130515 more ... alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PML mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PML mRNA CTD PMID:32699268 aluminium sulfate (anhydrous) multiple interactions ISO RGD:1557220 6480464 [Lipopolysaccharides co-treated with aluminum sulfate] results in increased expression of PML protein CTD PMID:23430110 amphetamine decreases expression ISO RGD:1562602 6480464 Amphetamine results in decreased expression of PML mRNA CTD PMID:30779732 Antimony trioxide affects localization EXP 6480464 antimony trioxide affects the localization of PML protein CTD PMID:9834237 Antimony trioxide increases degradation EXP 6480464 antimony trioxide results in increased degradation of PML protein mutant form CTD PMID:9834237 Antimony trioxide multiple interactions EXP 6480464 antimony trioxide promotes the reaction [SUMO1 protein binds to PML protein] CTD PMID:9834237 antimony(0) multiple interactions EXP 6480464 Antimony affects the localization of and results in increased sumoylation of PML protein CTD PMID:26049103 aristolochic acid increases expression EXP 6480464 aristolochic acid I results in increased expression of PML mRNA CTD PMID:33212167 aristolochic acid decreases expression EXP 6480464 aristolochic acid I results in decreased expression of PML protein CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PML mRNA CTD PMID:16934159 arsane increases degradation EXP 6480464 Arsenic results in increased degradation of PML protein CTD PMID:18408734 arsane multiple interactions EXP 6480464 RNF4 protein promotes the reaction [Arsenic results in increased degradation of PML protein] CTD PMID:18408734 arsenic atom multiple interactions EXP 6480464 RNF4 protein promotes the reaction [Arsenic results in increased degradation of PML protein] CTD PMID:18408734 arsenic atom increases degradation EXP 6480464 Arsenic results in increased degradation of PML protein CTD PMID:18408734 arsenite(3-) increases response to substance EXP 6480464 PML protein results in increased susceptibility to arsenite CTD PMID:24135626 arsenite(3-) affects binding EXP 6480464 arsenite binds to PML protein CTD PMID:28125064 arsenite(3-) increases sumoylation EXP 6480464 arsenite results in increased sumoylation of PML protein CTD PMID:24135626 arsenous acid affects binding EXP 6480464 Arsenic Trioxide binds to PML protein, Arsenic Trioxide binds to PML protein modified form CTD PMID:15748426 , PMID:20378816 arsenous acid decreases response to substance EXP 6480464 PML gene mutant form results in decreased susceptibility to Arsenic Trioxide more ... CTD PMID:21613260 more ... arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of PML protein modified form CTD PMID:20943951 arsenous acid decreases expression ISO RGD:1557220 6480464 Arsenic Trioxide results in decreased expression of PML protein CTD PMID:18469801 arsenous acid affects metabolic processing EXP 6480464 Arsenic Trioxide affects the metabolism of PML protein CTD PMID:21217775 arsenous acid increases degradation EXP 6480464 Arsenic Trioxide results in increased degradation of PML protein, Arsenic Trioxide results in increased degradation of PML protein mutant form CTD PMID:15748426 more ... arsenous acid increases response to substance EXP 6480464 PML mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:26118777 arsenous acid multiple interactions EXP 6480464 [[Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]] which results in increased degradation of PML protein alternative form more ... CTD PMID:15093545 more ... arsenous acid increases ubiquitination EXP 6480464 Arsenic Trioxide results in increased ubiquitination of PML protein, Arsenic Trioxide results in increased ubiquitination of PML protein alternative form CTD PMID:20378816 , PMID:23028697 arsenous acid affects response to substance EXP 6480464 PML protein affects the susceptibility to Arsenic Trioxide CTD PMID:21217775 arsenous acid multiple interactions ISO RGD:1557220 6480464 Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of PML protein], Arsenic Trioxide results in increased sumoylation of and results in increased localization of and results in increased degradation of [PML protein mutant form binds to PML protein mutant form] CTD PMID:20609355 , PMID:24762191 arsenous acid increases sumoylation EXP 6480464 Arsenic Trioxide results in increased sumoylation of PML protein, Arsenic Trioxide results in increased sumoylation of PML protein alternative form CTD PMID:17081986 more ... arsenous acid increases degradation ISO RGD:1557220 6480464 Arsenic Trioxide results in increased degradation of PML protein CTD PMID:21921037 , PMID:23430110 arsenous acid increases expression ISO RGD:1557220 6480464 Arsenic Trioxide results in increased expression of PML mRNA CTD PMID:21921037 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PML mRNA mutant form more ... CTD PMID:11721366 more ... arsenous acid affects localization EXP 6480464 Arsenic Trioxide affects the localization of PML protein CTD PMID:15622748 more ... ATP multiple interactions ISO RGD:1557220 6480464 [Lipopolysaccharides co-treated with Adenosine Triphosphate] promotes the reaction [NLRP3 protein binds to PML protein] more ... CTD PMID:23430110 benzo[a]pyrene increases mutagenesis EXP 6480464 Benzo(a)pyrene results in increased mutagenesis of PML gene CTD PMID:25435355 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PML mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of PML 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1557220 6480464 Benzo(a)pyrene results in decreased expression of PML mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1557220 6480464 Benzo(a)pyrene results in increased expression of PML mRNA CTD PMID:19770486 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1557220 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects expression ISO RGD:1562602 6480464 bisphenol A affects the expression of PML mRNA CTD PMID:25181051 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PML gene CTD PMID:31601247 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PML gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1557220 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bleomycin A2 increases expression ISO RGD:1557220 6480464 Bleomycin results in increased expression of PML protein CTD PMID:24762191 bleomycin A2 multiple interactions ISO RGD:1557220 6480464 arsenic trioxide inhibits the reaction [Bleomycin results in increased expression of PML protein] CTD PMID:24762191 buta-1,3-diene decreases expression ISO RGD:1557220 6480464 1, 3-butadiene results in decreased expression of PML mRNA CTD PMID:29038090 cadmium dichloride multiple interactions ISO RGD:1557220 6480464 PML gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of CCND1 protein], PML protein affects the reaction [Cadmium Chloride affects the localization of CCND1 mRNA] CTD PMID:12167712 cadmium dichloride affects localization ISO RGD:1557220 6480464 Cadmium Chloride affects the localization of PML protein CTD PMID:12167712 calciol multiple interactions EXP 6480464 PML protein mutant form inhibits the reaction [[Cholecalciferol co-treated with TGFB1 protein] results in increased expression of CD14 mRNA] CTD PMID:15988048 carbon nanotube increases expression ISO RGD:1557220 6480464 Nanotubes more ... CTD PMID:25554681 cisplatin increases expression ISO RGD:1557220 6480464 Cisplatin results in increased expression of PML mRNA CTD PMID:21151649 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PML mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PML mRNA CTD PMID:27392435 cobalt dichloride multiple interactions EXP 6480464 cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of PML protein mutant form] CTD PMID:16330433 Cuprizon decreases expression ISO RGD:1562602 6480464 Cuprizone results in decreased expression of PML mRNA CTD PMID:27523638 cycloheximide decreases degradation EXP 6480464 Cycloheximide results in decreased degradation of PML protein modified form CTD PMID:26049103 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [arsenic trioxide results in increased degradation of PML protein] CTD PMID:20943951 DAPT multiple interactions EXP 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 deoxynivalenol decreases phosphorylation ISO RGD:1557220 6480464 deoxynivalenol results in decreased phosphorylation of PML protein CTD PMID:23811945 deoxynivalenol affects phosphorylation ISO RGD:1557220 6480464 deoxynivalenol affects the phosphorylation of PML protein CTD PMID:23352502 diarsenic trioxide affects localization EXP 6480464 Arsenic Trioxide affects the localization of PML protein CTD PMID:15622748 more ... diarsenic trioxide decreases response to substance EXP 6480464 PML gene mutant form results in decreased susceptibility to Arsenic Trioxide more ... CTD PMID:21613260 more ... diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PML mRNA mutant form more ... CTD PMID:11721366 more ... diarsenic trioxide affects response to substance EXP 6480464 PML protein affects the susceptibility to Arsenic Trioxide CTD PMID:21217775 diarsenic trioxide increases degradation EXP 6480464 Arsenic Trioxide results in increased degradation of PML protein, Arsenic Trioxide results in increased degradation of PML protein mutant form CTD PMID:15748426 more ... diarsenic trioxide multiple interactions EXP 6480464 [[Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]] which results in increased degradation of PML protein alternative form more ... CTD PMID:15093545 more ... diarsenic trioxide increases expression ISO RGD:1557220 6480464 Arsenic Trioxide results in increased expression of PML mRNA CTD PMID:21921037 diarsenic trioxide increases degradation ISO RGD:1557220 6480464 Arsenic Trioxide results in increased degradation of PML protein CTD PMID:21921037 , PMID:23430110 diarsenic trioxide affects binding EXP 6480464 Arsenic Trioxide binds to PML protein, Arsenic Trioxide binds to PML protein modified form CTD PMID:15748426 , PMID:20378816 diarsenic trioxide decreases expression ISO RGD:1557220 6480464 Arsenic Trioxide results in decreased expression of PML protein CTD PMID:18469801 diarsenic trioxide increases ubiquitination EXP 6480464 Arsenic Trioxide results in increased ubiquitination of PML protein, Arsenic Trioxide results in increased ubiquitination of PML protein alternative form CTD PMID:20378816 , PMID:23028697 diarsenic trioxide increases response to substance EXP 6480464 PML mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:26118777 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of PML protein modified form CTD PMID:20943951 diarsenic trioxide affects metabolic processing EXP 6480464 Arsenic Trioxide affects the metabolism of PML protein CTD PMID:21217775 diarsenic trioxide increases sumoylation EXP 6480464 Arsenic Trioxide results in increased sumoylation of PML protein, Arsenic Trioxide results in increased sumoylation of PML protein alternative form CTD PMID:17081986 more ... diarsenic trioxide multiple interactions ISO RGD:1557220 6480464 Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of PML protein], Arsenic Trioxide results in increased sumoylation of and results in increased localization of and results in increased degradation of [PML protein mutant form binds to PML protein mutant form] CTD PMID:20609355 , PMID:24762191 dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of PML mRNA CTD PMID:28302478 dimercaprol multiple interactions EXP 6480464 Dimercaprol inhibits the reaction [4-aminophenylarsenoxide binds to PML protein] CTD PMID:26598702 dimethylarsinous acid multiple interactions EXP 6480464 [monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased degradation of PML protein CTD PMID:29774349 dioxygen affects methylation ISO RGD:1557220 6480464 Oxygen deficiency affects the methylation of PML promoter CTD PMID:24205000 dioxygen multiple interactions ISO RGD:1562602 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PML mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PML mRNA CTD PMID:33729688 dioxygen increases expression ISO RGD:1557220 6480464 Oxygen deficiency results in increased expression of PML mRNA CTD PMID:24205000 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases degradation EXP 6480464 Antimony Potassium Tartrate results in increased degradation of PML protein mutant form CTD PMID:9834237 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate affects localization EXP 6480464 Antimony Potassium Tartrate affects the localization of PML protein CTD PMID:9834237 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein] CTD PMID:9834237 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PML mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PML mRNA CTD PMID:29803840 elemental selenium multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in increased expression of PML mRNA CTD PMID:19244175 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of PML mRNA CTD PMID:19244175 ellagic acid decreases expression EXP 6480464 Ellagic Acid results in decreased expression of PML mRNA CTD PMID:12002526 endosulfan decreases expression ISO RGD:1562602 6480464 Endosulfan results in decreased expression of PML mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PML protein CTD PMID:23301498 erlotinib hydrochloride increases localization EXP 6480464 Erlotinib Hydrochloride results in increased localization of PML protein CTD PMID:23440206 erlotinib hydrochloride decreases response to substance EXP 6480464 PML protein results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:23440206 erlotinib hydrochloride increases expression EXP 6480464 Erlotinib Hydrochloride results in increased expression of PML protein CTD PMID:23440206 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of PML mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:1557220 6480464 fenamidone results in increased expression of PML mRNA CTD PMID:27029645 fenofibrate multiple interactions EXP 6480464 Fenofibrate promotes the reaction [Arsenic Trioxide results in decreased expression of PML protein mutant form] CTD PMID:32929351 fenvalerate affects methylation ISO RGD:1557220 6480464 fenvalerate affects the methylation of PML gene CTD PMID:23548413 fluoranthene multiple interactions ISO RGD:1557220 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PML mRNA CTD PMID:28329830 fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PML gene CTD PMID:31601247 gentamycin decreases expression ISO RGD:1562602 6480464 Gentamicins results in decreased expression of PML mRNA CTD PMID:33387578 Ginkgoic acid decreases response to substance ISO RGD:1557220 6480464 PML protein results in decreased susceptibility to ginkgolic acid CTD PMID:29524504 Ginkgoic acid multiple interactions ISO RGD:1557220 6480464 ginkgolic acid inhibits the reaction [AGT protein modified form results in increased sumoylation of PML protein] more ... CTD PMID:29524504 hydroxyurea increases expression ISO RGD:1557220 6480464 Hydroxyurea results in increased expression of PML mRNA CTD PMID:27208086 ibuprofen affects expression EXP 6480464 Ibuprofen affects the expression of PML mRNA CTD PMID:17070997 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of PML protein CTD PMID:32959892 leptomycin B multiple interactions ISO RGD:1557220 6480464 leptomycin B inhibits the reaction [Lipopolysaccharides results in increased localization of PML protein] CTD PMID:23430110 lipopolysaccharide multiple interactions ISO RGD:1557220 6480464 [Lipopolysaccharides co-treated with Adenosine Triphosphate] promotes the reaction [NLRP3 protein binds to PML protein] more ... CTD PMID:23430110 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PML protein CTD PMID:30501627 lipopolysaccharide increases localization ISO RGD:1557220 6480464 Lipopolysaccharides results in increased localization of PML protein CTD PMID:23430110 lipopolysaccharide increases expression ISO RGD:1557220 6480464 Lipopolysaccharides results in increased expression of PML mRNA, Lipopolysaccharides results in increased expression of PML protein CTD PMID:12057914 , PMID:23430110 malathion decreases expression EXP 6480464 Malathion results in decreased expression of PML mRNA CTD PMID:32069766 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of PML mRNA CTD PMID:23649840 mitoxantrone affects mutagenesis EXP 6480464 Mitoxantrone affects the mutagenesis of PML gene CTD PMID:19884644 N-(6-acetamidohexyl)acetamide multiple interactions EXP 6480464 [Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of PML protein mutant form CTD PMID:12130515 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of PML protein modified form CTD PMID:26049103 N-nitrosodiethylamine increases expression ISO RGD:1557220 6480464 Diethylnitrosamine results in increased expression of PML mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1557220 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PML mRNA] CTD PMID:17854601 nickel atom increases expression EXP 6480464 Nickel results in increased expression of PML mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PML mRNA more ... CTD PMID:32699268 p-menthan-3-ol decreases expression EXP 6480464 Menthol results in decreased expression of PML mRNA CTD PMID:26760959 paraquat multiple interactions ISO RGD:1557220 6480464 Paraquat promotes the reaction [PML protein binds to PML protein], Paraquat results in increased sumoylation of and results in increased localization of and results in increased degradation of [PML protein mutant form binds to PML protein mutant form] CTD PMID:20609355 pentachlorophenol increases expression ISO RGD:1557220 6480464 Pentachlorophenol results in increased expression of PML mRNA CTD PMID:23892564 phenylarsine oxide multiple interactions EXP 6480464 oxophenylarsine results in increased sumoylation of and results in increased ubiquitination of and results in increased degradation of PML protein, oxophenylarsine results in increased sumoylation of and results in increased ubiquitination of and results in increased degradation of PML protein mutant form CTD PMID:28125064 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PML mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1557220 6480464 pirinixic acid results in decreased expression of PML mRNA CTD PMID:17426115 propiconazole decreases expression ISO RGD:1557220 6480464 propiconazole results in decreased expression of PML mRNA CTD PMID:21278054 puerarin multiple interactions EXP 6480464 arsenic trioxide promotes the reaction [puerarin results in decreased expression of PML mRNA alternative form] CTD PMID:20416161 puerarin decreases expression EXP 6480464 puerarin results in decreased expression of PML mRNA alternative form CTD PMID:20416161 reactive oxygen species multiple interactions ISO RGD:1557220 6480464 PML protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased abundance of Reactive Oxygen Species] CTD PMID:23430110 resiquimod multiple interactions ISO RGD:1557220 6480464 PML protein promotes the reaction [[resiquimod co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein] CTD PMID:23430110 resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PML mRNA more ... CTD PMID:19631782 , PMID:23557933 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of PML mRNA CTD PMID:25436977 rofecoxib increases expression EXP 6480464 rofecoxib results in increased expression of PML mRNA CTD PMID:17070997 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PML mRNA CTD PMID:27188386 selenium atom multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in increased expression of PML mRNA CTD PMID:19244175 selenium atom increases expression EXP 6480464 Selenium results in increased expression of PML mRNA CTD PMID:19244175 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of PML mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of PML mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:1557220 6480464 Silver results in decreased expression of PML mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1557220 6480464 Silver results in decreased expression of PML mRNA CTD PMID:27131904 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of PML protein CTD PMID:23440206 sirolimus increases localization EXP 6480464 Sirolimus results in increased localization of PML protein CTD PMID:23440206 sirolimus decreases response to substance EXP 6480464 PML protein results in decreased susceptibility to Sirolimus CTD PMID:23440206 sodium arsenate increases expression ISO RGD:1557220 6480464 sodium arsenate results in increased expression of PML mRNA CTD PMID:21795629 sodium arsenite multiple interactions EXP 6480464 PML protein mutant form inhibits the reaction [sodium arsenite results in increased sumoylation of and results in increased ubiquitination of and results in increased degradation of PML protein] more ... CTD PMID:26049103 , PMID:28125064 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PML protein CTD PMID:30528433 sodium arsenite decreases response to substance EXP 6480464 PML protein mutant form results in decreased susceptibility to sodium arsenite CTD PMID:28125064 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PML mRNA CTD PMID:12016162 sulindac increases expression EXP 6480464 Sulindac results in increased expression of PML mRNA CTD PMID:16273229 tetrachloromethane decreases expression ISO RGD:1562602 6480464 Carbon Tetrachloride results in decreased expression of PML mRNA CTD PMID:31150632 thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of PML mRNA CTD PMID:27188386 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of PML protein CTD PMID:30910687 toluene decreases expression EXP 6480464 Toluene results in decreased expression of PML mRNA CTD PMID:33438815 toluene increases methylation EXP 6480464 Toluene results in increased methylation of PML gene CTD PMID:33438815 Triptolide increases expression ISO RGD:1562602 6480464 triptolide results in increased expression of PML protein CTD PMID:32519852 triptonide affects expression ISO RGD:1557220 6480464 triptonide affects the expression of PML mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1557220 6480464 troglitazone results in decreased expression of PML mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1557220 6480464 Tungsten results in decreased expression of PML mRNA CTD PMID:30912803 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PML mRNA CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PML mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:1557220 6480464 Valproic Acid affects the expression of PML mRNA CTD PMID:17963808 vanadyl sulfate decreases expression EXP 6480464 vanadyl sulfate results in decreased expression of PML mRNA CTD PMID:16330358 vitamin E multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in increased expression of PML mRNA CTD PMID:19244175 vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of PML mRNA CTD PMID:19244175 vorinostat multiple interactions EXP 6480464 [vorinostat co-treated with arsenic trioxide] results in decreased expression of PML protein mutant form more ... CTD PMID:19631782 , PMID:27189198 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of PML protein mutant form CTD PMID:27189198 zebularine decreases expression EXP 6480464 pyrimidin-2-one beta-ribofuranoside results in decreased expression of PML mRNA CTD PMID:19194470 zinc atom increases expression EXP 6480464 Zinc results in increased expression of PML protein mutant form CTD PMID:16330433 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of PML protein mutant form CTD PMID:16330433